Charco Neurotech’s first trials of its wearable device for people with Parkinson’s are proving so successful that the test candidates are reluctant to hand the gadget back to the medtech start-up.
Charco Neurotech prepares to relaunch CUE1+ following trial findings and medical device certification. Read article
Read moreResults from a clinical trial of CUE1+, a chest-mounted device, has shown it’s well tolerated by people with…
Read moreA double-blind, placebo-controlled study of 50 people with Parkinson’s, published in Parkinson’s Disease, part of the Nature Portfolio, is the first…
Read more
